Antheia Inks $73M Series B Financing Round

Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, has raised $73 million in Series B financing.
Antheia nabs $73M for synthetic biology platform

Antheia has raised $73 million to support the commercialization of its first pharmaceutical compound and the scale-up of production of active pharmaceutical ingredients and key starting materials on its synthetic biology platform…
Antheia advances API biomanufacturing

Company’s SynBio platform enables manufacturing of complex plant-based drugs Biomanufacturing and synthetic biology (SynBio) manufacturing platforms have the potential to create more resilient supply chains for essential medicines by producing…
Could synthetic biology solutions fix supply chain challenges?

An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes…
New Coalition Dedicated To Fostering American Synthetic Biology Manufacturing Launched Today

Today, three leading synthetic biology companies announced the launch of the Synthetic Biology (SynBio) Coalition (www.synbioco.com) to promote investment and support for the American synthetic biology industry…
Fixing essential medicine shortages: obstacles and opportunities

Global health experts and governing bodies agree that everyone has a right to access the medicines they need. The COVID-19 pandemic and resulting drug shortages have underscored the critical need to protect this right…
Investing in the next wave of biomanufacturing technologies for pharma

The global pandemic has brought pharmaceutical manufacturing to the forefront of America’s public consciousness. Acute drug shortages brought on by COVID-19 have underscored the need for domestic production and more resilient supply chains…
COVID-19 Vaccine Transforms Pharma Supply Chain Forever

The intricacies of the pharmaceutical supply chain may not have been in the mainstream news a few years ago, but recent events kicked this subject to front page news…
Meet the Team – Our Lab Operations Team

For the final installation in our “Meet the Team” series, we hear from Olivia, Khurram and Vicky, who lead our operations. This team is the key to ensuring Antheia’s labs are running successfully and efficiently…
Scaling synthetic biology as a manufacturing platform

For decades, synthetic biology has promised to make manufacturing more efficient, sustainable, and responsive to sudden changes in supply and demand. It has the potential to create new value across industries by transforming everything from food to pharmaceuticals…